发明授权
US5854070A Murine and humanizer 23F2G antibodies and cell lines expressing said antibodies 失效
鼠和人源化23F2G抗体和表达所述抗体的细胞系

Murine and humanizer 23F2G antibodies and cell lines expressing said
antibodies
摘要:
Disclosed are methods for the alleviation of symptoms associated with inflammatory disease states, and more particularly to the inhibition of inflammatory processes associated with the multiple sclerosis disease, by administering a pharmaceutically effective amount of antibody substance immunologically reactive with the common .beta. chain (CD18) of human leukocyte integrins and/or competes with mAb 60.3 for binding to human LFA-1.
公开/授权文献
信息查询
0/0